ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
ViiV Healthcare and UNC-Chapel Hill expand HIV cure partnership pharmaceutical-technology
March 11, 2020Glaxo-Smith-Kline’s human immunodeficiency virus (HIV) specialist company ViiV Healthcare has renewed its public-private research partnership with University of North Carolina at Chapel Hill (UNC-Chapel Hill) for another five years with a $20m investment.
Pharma Sources Insight July 2025
